3D-Monophosphoryl Lipid (14) (ammonium)
3D-Monophosphoryl Lipid (14) (3D-MPL (14) ) ammonium is a TLR agonist that can be used as a vaccine adjuvant to enhance the immunogenicity of vaccines[1].
Product Specifications
Product Name Alternative
3D-MPL (14) (ammonium)
UNSPSC
12352005
Target
Toll-like Receptor (TLR)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/3d-monophosphoryl-lipid-14-ammonium.html
Smiles
CCCCCCCCCCCCCC(O[C@H](CCCCCCCCCCC)CC(O[C@@H]1[C@H]([C@@H](O[C@@H]([C@H]1OP(O)(O)=O)CO)OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)NC(C[C@@H](CCCCCCCCCCC)OC(CCCCCCCCCCCCC)=O)=O)NC(C[C@@H](CCCCCCCCCCC)OC(CCCCCCCCCCCCC)=O)=O)=O)=O.N
Molecular Formula
C96H184N3O21P
Molecular Weight
1747.47
References & Citations
[1]Mata-Haro V, et al. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science. 2007 Jun 15;316 (5831) :1628-32.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
252910-APC 100 µL
TP53RK (TP53 Regulating Kinase, BUD32, C20orf64, Nori-2, Nori-2p, PRPK, dJ101A2) (APC)
Ask
View Details 
E3440-09G-ML490 100 µL
Epstein Barr Virus, Capsid Antigen p160 (EBV, Human Herpes virus 4, HHV4) (MaxLight 490) discontinued
Ask
View Details 